These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358 [TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer. Zhang J; Huang M; Cai Y; Wang L; Xiao J; Lan P; Hu H; Wu X; Ling J; Peng J; Chen D; Kang L; Zhang Y; Ren D; Wang H; Chen S; Lin F; Zheng J; Zhou Z; Wang J; Deng Y Clin Colorectal Cancer; 2019 Dec; 18(4):238-244. PubMed ID: 31378655 [TBL] [Abstract][Full Text] [Related]
25. Chemotherapy Alone for Patients With Stage II/III Rectal Cancer Undergoing Radical Surgery. AlGizawy SM; Essa HH; Ahmed BM Oncologist; 2015 Jul; 20(7):752-7. PubMed ID: 26040621 [TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial. Deng Y; Chi P; Lan P; Wang L; Chen W; Cui L; Chen D; Cao J; Wei H; Peng X; Huang Z; Cai G; Zhao R; Huang Z; Xu L; Zhou H; Wei Y; Zhang H; Zheng J; Huang Y; Zhou Z; Cai Y; Kang L; Huang M; Wu X; Peng J; Ren D; Wang J J Clin Oncol; 2019 Dec; 37(34):3223-3233. PubMed ID: 31557064 [TBL] [Abstract][Full Text] [Related]
27. A Feasibility Study of Neoadjuvant XELOX Without Radiotherapy for Locally Advanced Lower Rectal Cancer. Ueki T; Manabe T; Inoue S; Ienaga J; Yamanaka N; Egami T; Ishikawa M; Konomi H; Ikubo A; Nagayoshi K; Nakamura M; Tanaka M Anticancer Res; 2016 Feb; 36(2):741-7. PubMed ID: 26851033 [TBL] [Abstract][Full Text] [Related]
28. Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer in Elderly Patients: Toxicity, Disease Control, and Survival Outcomes. De Felice F; Llange K; Rubini F; Bulzonetti N; Caiazzo R; Musio D; Tombolini V Clin Colorectal Cancer; 2018 Mar; 17(1):e77-e81. PubMed ID: 29113729 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial. Koike J; Funahashi K; Yoshimatsu K; Yokomizo H; Kan H; Yamada T; Ishida H; Ishibashi K; Saida Y; Enomoto T; Katsumata K; Hisada M; Hasegawa H; Koda K; Ochiai T; Sakamoto K; Shiokawa H; Ogawa S; Itabashi M; Kameoka S Cancer Chemother Pharmacol; 2017 Mar; 79(3):519-525. PubMed ID: 28150022 [TBL] [Abstract][Full Text] [Related]
31. Medium-term results of neoadjuvant systemic chemotherapy using irinotecan, 5-fluorouracil, and leucovorin in patients with locally advanced rectal cancer. Ishii Y; Hasegawa H; Endo T; Okabayashi K; Ochiai H; Moritani K; Watanabe M; Kitagawa Y Eur J Surg Oncol; 2010 Nov; 36(11):1061-5. PubMed ID: 20538422 [TBL] [Abstract][Full Text] [Related]
32. A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer. Kudo T; Takemasa I; Hata T; Sakai D; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Satoh T; Mizushima T; Mori M; Doki Y Oncology; 2019; 97(4):211-216. PubMed ID: 31266024 [TBL] [Abstract][Full Text] [Related]
33. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. ; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336 [TBL] [Abstract][Full Text] [Related]
34. Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II). Hattori N; Nakayama G; Uehara K; Aiba T; Ishigure K; Sakamoto E; Tojima Y; Kanda M; Kobayashi D; Tanaka C; Yamada S; Koike M; Fujiwara M; Nagino M; Kodera Y Int J Clin Oncol; 2020 Jan; 25(1):118-125. PubMed ID: 31542847 [TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023 [TBL] [Abstract][Full Text] [Related]
36. Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial. Deng Y; Chi P; Lan P; Wang L; Chen W; Cui L; Chen D; Cao J; Wei H; Peng X; Huang Z; Cai G; Zhao R; Huang Z; Xu L; Zhou H; Wei Y; Zhang H; Zheng J; Huang Y; Zhou Z; Cai Y; Kang L; Huang M; Peng J; Ren D; Wang J J Clin Oncol; 2016 Sep; 34(27):3300-7. PubMed ID: 27480145 [TBL] [Abstract][Full Text] [Related]
37. Improved Outcomes for Responders After Treatment with Induction Chemotherapy and Chemo(re)irradiation for Locally Recurrent Rectal Cancer. Voogt ELK; van Zoggel DMGI; Kusters M; Nieuwenhuijzen GAP; Bloemen JG; Peulen HMU; Creemers GJM; van Lijnschoten G; Nederend J; Roef MJ; Burger JWA; Rutten HJT Ann Surg Oncol; 2020 Sep; 27(9):3503-3513. PubMed ID: 32193717 [TBL] [Abstract][Full Text] [Related]